Assertio Holdings, Inc.
ASRTCIK 0001808665 · Pharmaceutical Preparations · Nasdaq
- Assertio Therapeutics, Inc (until 2019-05-10)
- DEPOMED INC (until 2016-05-26)
- DEPOMED INC (until 2016-05-26)
Revenue (TTM)
$115.1M
−5.0% YoY
Q1 May 2026
Net Income (TTM)
−$37.3M
−40.7% YoY
Q1 May 2026
EPS Diluted (TTM)
−$5.11
−39.4% YoY
Q1 May 2026
Gross Margin
86.2%
Q1 May 2026
Operating Margin
-24.6%
Q1 May 2026
Net Margin
-32.4%
Q1 May 2026
Free Cash Flow (TTM)
$26.25M
Q1 May 2026
Cash
$33.71M
Q1 May 2026
Total Debt
$41.42M
Q1 May 2026
Shares Outstanding
6.46M sh
Q1 May 2026